CIK 0001367644
- Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 141902018
- Phone
- +1 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-30 | Fowler Neal Franklin Director | Grant or award | +25,344 | 160,847 | ||
| 2026-04-30 | Fowler Neal Franklin Director | Grant or award · Stock Option (Right to Buy) | +11,296 | 11,296 | ||
| 2025-04-30 | Fowler Neal Franklin Director | Grant or award | +34,403 | 135,503 | ||
| 2025-04-30 | Fowler Neal Franklin Director | Grant or award · Stock Option (Right to Buy) | +15,824 | 41,572 | ||
| 2025-03-12 | Fowler Neal Franklin Director | Sale | −35,000 | $5.83 | $204K | 101,100 |
| 2024-05-23 | Fowler Neal Franklin Director | Grant or award | +17,430 | 136,100 | ||
| 2024-05-23 | Fowler Neal Franklin Director | Grant or award · Stock Option (Right to Buy) | +25,748 | 25,748 | ||
| 2023-10-03 | Fowler Neal Franklin Director | Grant or award | +118,670 | 118,670 |
Page 1 of 1 · 8 trades